Day One Biopharmaceuticals, Inc. (DAWN) Analyst Estimates Quarterly

Day One Biopharmaceuticals, Inc.

DAWN (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2025 12-30	2025 09-30	2025 06-30	2025 03-30	2024 12-30	2024 09-30	2024 06-30
Number of Analysts	1234	7	7	8	6	7	7	6
Estimated Revenue
Low	1234	43.56	36.94	33.03	29.55	24.61	10.66	0.684
Average	1234	46.66	37.82	34.93	30.27	27.83	28.48	1.03
High	1234	53.42	40.07	37.23	31.05	29.77	61.91	1.43
Estimated EBITDA
Low	1234	29.11	24.69	22.07	19.75	16.45	7.12	0.457
Average	1234	31.18	25.28	23.35	20.23	18.6	19.04	0.686
High	1234	35.7	26.78	24.88	20.76	19.9	41.38	0.953
Estimated EBIT
Low	1234	28.98	24.57	21.97	19.66	16.37	7.09	0.455
Average	1234	31.04	25.16	23.24	20.14	18.51	18.95	0.683
High	1234	35.54	26.65	24.77	20.66	19.81	41.19	0.948
Estimated Net Income
Low	1234	-23.01	-32.88	-42.98	-49.51	-41.75	-119.1	-90.36
Average	1234	-19.18	-30.69	-36.86	-45.27	-37.47	-32.62	-77.62
High	1234	-11.51	-28.5	-26.86	-41.03	-33.19	48.93	-27.8
Estimated SGA Expenses
Low	1234	42.51	36.05	32.24	28.84	24.02	10.4	0.668
Average	1234	45.54	36.92	34.09	29.54	27.16	27.8	1
High	1234	52.14	39.11	36.34	30.31	29.06	60.43	1.39
Estimated EPS
Low	1234	-0.223	-0.318	-0.416	-0.479	-0.404	-1.15	-0.874
Average	1234	-0.186	-0.297	-0.357	-0.438	-0.362	-0.316	-0.751
High	1234	-0.111	-0.276	-0.26	-0.397	-0.321	0.473	-0.269

Market is Open